RETINAL VEIN OCCLUSION

This early study tests a new drug, ANXV, in 12 adults with diabetic retinopathy or retinal vein occlusion. The main goal is to check if ANXV is safe and if it can improve vision or reduce the need for other treatments. Participants receive ANXV as a 30-minute infusion daily for 5…

This early-stage study tests a new dye called MB-102 for taking pictures of the back of the eye (ocular angiography). The goal is to see if it is safe and produces good images compared to the standard dye (fluorescein sodium). About 10 adults with healthy or diseased eyes will pa…

This study looks at a protein called sCD160 in the eye fluids and blood of people with diabetic retinopathy or retinal vein occlusion. Researchers want to see if higher levels of this protein are linked to more severe eye damage. The goal is to better understand these vision-thre…

This study collects blood, tissue, and health information from people with and without retinal diseases like age-related macular degeneration and diabetic retinopathy. The goal is to create a research database to help scientists understand why some people get eye diseases and oth…

This study uses a special eye scan (OCT angiography) to take detailed pictures of blood vessels in the retina. Researchers will follow about 1,050 people with retinal diseases (like diabetic retinopathy) and healthy volunteers over time. The goal is to find better ways to detect …